Biological specimen

New Security Concerns about DTC Genetic Testing Raised

In a UC Davis study, researchers described methods by which someone could learn database genotypes by uploading multiple datasets. For example, a person who uploads approximately 900 genomes could recover at least one allele at SNP sites across up to 82% of the genome of a median person of European ancestries.

Nanoparticle-Based Urine Test for Early Lung Cancer Detection Developed

MIT engineers have developed nanoparticles that can be delivered to the lungs, where tumor-associated proteases cut peptides on the surface of the particles, releasing reporter molecules. Those reporters can be detected by a urine test.

Genomenon Wins SBIR Grant to Develop ‘Micropublications’ for Variant Interpretation

Genomenon said today it has won a Small Business Innovation Research (SBIR) grant from the NIH’s National Human Genome Research Institute (NHGRI). Funding from the...
Myriad Genetics' myChoice HRD Plus test will be used by AstraZeneca in an exploratory analysis to identify women with advanced ovarian cancer who may benefit from maintenance treatment with a combination of AZ’s Lynparza® (olaparib) and the Genentech (Roche) cancer drug Avastin® (bevacizumab). [Source: OGphoto / Getty Images]

AZ to Use Myriad’s myChoice HRD Plus Test in Phase III Trial

Myriad Genetics will use myChoice HRD Plus to evaluate patients enrolled in an ongoing Phase III trial, in order to identify HRD cases
Geisinger Health System Huntington F Willard

Genome Medical Taps Hunt Willard to Lead New Population Genomics Program

The change of scenery for Willard comes after a 10-year association with Geisinger Health, the last two years spearheading the launch of Geisinger National Precision Health.
Source: Children's Hospital of Philadelphia

Kids First Data Resource Center Aims to Explain Links between Childhood Cancers and Birth...

Helping to fill knowledge gaps on the relationship between childhood cancer and birth defects will be among goals of the Kids First DRC.
This visual abstract depicts how researchers utilize single-cell phosphoproteomic analysis of patient derived glioblastoma models to identify shifts in signaling coordination following short-term treatment with kinase inhibitors

Single-Cell Proteomics Helps Researchers Map Routes to Cancer Drug Resistance

Scientists found a way to map the alternate routes mutated cells use, suggesting approaches for developing more effective drug therapies.
Source: selvanegra/Getty Images

MD Anderson, Affimed Ink Immuno-Oncology Development Deal

The collaboration will study the combination of Affimed's TandAb candidate AFM13 with MD Anderson's natural killer cell technology.
Skin cells from a patient with X-linked retinitis pigmentosa were transformed into induced pluripotent stem cells

CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect

Marking yet another CRISPR-related first, scientists have replaced a defective gene associated with a sensory disease in stem cells that were derived from a...
ArcherDX said its Archer Immunoverse and VariantPlex NGS assays will be used by Ambry toward offering its biopharma customers large-scale immune repertoire analysis and chimeric antigen T-cell receptor (CAR-T) manufacturing characterization and pharmacodynamics. [royaltystockphoto/Getty Images]

ArcherDX, Ambry to Offer Immune Repertoire, CAR-T-Related Sequencing Services

Ambry to use ArcherDX's Immunoverse and VariantPlex NGS assays in immune repertoire, CAR-T characterization, pharmacodynamics services.
Scroll Up